Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.
Important takeaways for all competitive exams:
The Telangana government has become the first in India to implement Scheduled Castes (SC) sub-categorisation,…
There is a famous city in Ukraine that is known for its rich history, old…
Every year in mid-April, India remembers the heartbreaking Jallianwala Bagh massacre. On April 13, 1919,…
Every year on April 13, Siachen Day is observed to honour the indomitable courage and…
In a strategic branding move, Milkfed Punjab, one of India’s largest state dairy cooperatives, has…
India showcased a powerful start to the international shooting season, securing the second position overall…